Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2011
Open label, three period, single sequence, study of 5, 25, 50 mg sertraline pharmacokinetics in healthy male Korean volunteersM K Park, K-H Shin, K-P Kim, et al.Arzneimittel-Forschung|September 1, 1994
General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II)D K Kim, J S Ahn, G Ryu, et al.Cancer Chemotherapy and Pharmacology|January 27, 1998
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) H T Kim, D K Kim, Y B Cho, et al.Journal of Korean Medical Science|August 21, 2001
Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?K Y Na, J S Han, Y S Kim, et al.Clinical Pharmacology and Therapeutics|May 29, 2000
Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjectsY R Yoon, I J Cha, J H Shon, et al.Clinical Pharmacology and Therapeutics|April 20, 2001
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19K S Yu, D S Yim, J Y Cho, et al.Cancer|April 13, 2001
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignanciesN K Kim, T Y Kim, S G Shin, et al.International Journal of Clinical Pharmacology and Therapeutics|May 6, 2011
Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteersS Yi, J W Kim, T-E Kim, et al.Journal of Clinical Pharmacology|July 7, 2000
Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersI J Jang, K S Yu, J H Shon, et al.Journal of Clinical Psychopharmacology|June 1, 1996
Effect of rifampin on the plasma concentration and the clinical effect of haloperidol concomitantly administered to schizophrenic patientsY H Kim, I J Cha, J C Shim, et al.Pageof 5